Skip to main content

Abstract

Proton intracranial radiosurgery (SRS) and fractionated stereotactic (FSRT) treatments have a long history, dating back to the 1960s. Proton SRS/FSRT treatments have predominantly focused on benign intracranial conditions such as meningioma, arteriovenous malformation (AVM), pituitary adenoma, and vestibular schwannoma. Dosimetric comparisons between proton and photon SRS delivery have revealed superior normal tissue-sparing effect of protons, predominantly seen with large and irregularly shaped lesions, and most obvious in the low isodose regions. Clinical data demonstrate that proton SRS achieves control rates comparable to those achieved with photon techniques. These excellent outcomes are achieved with minimal acute and few late toxicities. These results therefore support the use of proton SRS/FSRT, especially in patients who will likely be long-term survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Davis JN, Medbery C 3rd, Sharma S, Danish A, Mahadevan A. The RSSearch Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy. Radiat Oncol. 2013;8:275.

    Article  Google Scholar 

  2. Chen CC, Chapman P, Petit J, Loeffler J. Proton radiosurgery in neurosurgery. Neurosurg Focus. 2007;23(6):E5.

    Article  Google Scholar 

  3. Verhey LJ, Smith V, Serago CF. Comparison of radiosurgery treatment modalities based on physical dose distributions. Int J Radiat Oncol Biol Phys. 1998;40(2):497–505.

    Article  CAS  Google Scholar 

  4. Smith V, Verhey L, Serago CF. Comparison of radiosurgery treatment modalities based on complication and control probabilities. Int J Radiat Oncol Biol Phys. 1998;40(2):507–13.

    Article  CAS  Google Scholar 

  5. Baumert BG, Norton IA, Lomax AJ, Davis JB. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions. Int J Radiat Oncol Biol Phys. 2004;60(4):1314–24.

    Article  Google Scholar 

  6. Baumert BG, Lomax AJ, Miltchev V, Davis JB. A comparison of dose distributions of proton and photon beams in stereotactic conformal radiotherapy of brain lesions. Int J Radiat Oncol Biol Phys. 2001;49(5):1439–49.

    Article  CAS  Google Scholar 

  7. Serago CF, Thornton AF, Urie MM, Chapman P, Verhey L, Rosenthal SJ. and coauthors. Comparison of proton and x-ray conformal dose distributions for radiosurgery applications. Med Phys. 1995;22(12):2111–6.

    Article  CAS  Google Scholar 

  8. Weber DC, Lomax AJ, Rutz HP, Stadelmann O, Egger E, Timmermann B, et al. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother Oncol. 2004;71(3):251–8.

    Article  Google Scholar 

  9. Slater JD, Loredo LN, Chung A, Bush DA, Patyal B, Johnson WD, et al. Fractionated proton radiotherapy for benign cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2012;83(5):e633–7.

    Article  Google Scholar 

  10. Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La Monte S, et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48(5):1363–70.

    Article  CAS  Google Scholar 

  11. Noel G, Habrand JL, Mammar H, Haie-Meder C, Pontvert D, Dederke S, et al. Highly conformal therapy using proton component in the management of meningiomas. Preliminary experience of the Centre de Protontherapie d’Orsay. Strahlenther Onkol. 2002;178(9):480–5.

    Article  Google Scholar 

  12. Noel G, Bollet MA, Calugaru V, Feuvret L, Haie-Meder C, Dhermain F, et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys. 2005;62(5):1412–22.

    Article  Google Scholar 

  13. Vernimmen F. Intracranial stereotactic radiation therapy with charged particle beams: an opportunity to regain the momentum. Int J Radiat Oncol Biol Phys. 2016;95(1):52–5.

    Article  Google Scholar 

  14. Vernimmen FJ, Harris JK, Wilson JA, Melvill R, Smit BJ, Slabbert JP. Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys. 2001;49(1):99–105.

    Article  CAS  Google Scholar 

  15. Morita A, Coffey RJ, Foote RL, Schiff D, Gorman D. Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg. 1999;90(1):42–9.

    Article  CAS  Google Scholar 

  16. Chang SD, Adler JR Jr, Martin DP. LINAC radiosurgery for cavernous sinus meningiomas. Stereotact Funct Neurosurg. 1998;71(1):43–50.

    Article  CAS  Google Scholar 

  17. Gudjonsson O, Blomquist E, Nyberg G, Pellettieri L, Montelius A, Grusell E, et al. Stereotactic irradiation of skull base meningiomas with high energy protons. Acta Neurochir. 1999;141(9):933–40.

    Article  CAS  Google Scholar 

  18. Vlachogiannis P, Gudjonsson O, Montelius A, Grusell E, Isacsson U, Nilsson K, et al. Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas. Acta Neurochir. 2017;159(12):2391–400.

    Article  Google Scholar 

  19. Halasz LM, Bussiere MR, Dennis ER, Niemierko A, Chapman PH, Loeffler JS, et al. Proton stereotactic radiosurgery for the treatment of benign meningiomas. Int J Radiat Oncol Biol Phys. 2011;81(5):1428–35.

    Article  Google Scholar 

  20. Lee JY, Niranjan A, McInerney J, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg. 2002;97(1):65–72.

    Article  Google Scholar 

  21. Kjellberg RN, Hanamura T, Davis KR, Lyons SL, Adams RD. Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med. 1983;309(5):269–74.

    Article  CAS  Google Scholar 

  22. Amin-Hanjani S, Ogilvy CS, Candia GJ, Lyons S, Chapman PH. Stereotactic radiosurgery for cavernous malformations: Kjellberg’s experience with proton beam therapy in 98 cases at the Harvard Cyclotron. Neurosurgery. 1998;42(6):1229–36; discussion 1236–1228

    Article  CAS  Google Scholar 

  23. Hattangadi-Gluth JA, Chapman PH, Kim D, Kim D, Niemierko A, Bussière MR, et al. Single-fraction proton beam stereotactic radiosurgery for cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2014;89(2):338–46.

    Article  Google Scholar 

  24. Karlsson B, Lindquist C, Steiner L. Prediction of obliteration after gamma knife surgery for cerebral arteriovenous malformations. Neurosurgery. 1997;40(3):425–30; discussion 430–421

    CAS  PubMed  Google Scholar 

  25. Starke RM, Yen CP, Ding D, Sheehan JP. A practical grading scale for predicting outcome after radiosurgery for arteriovenous malformations: analysis of 1012 treated patients. J Neurosurg. 2013;119(4):981–7.

    Article  Google Scholar 

  26. Barker FG 2nd, Butler WE, Lyons S, Cascio E, Ogilvy CS, Loeffler JS, et al. Dose-volume prediction of radiation-related complications after proton beam radiosurgery for cerebral arteriovenous malformations. J Neurosurg. 2003;99(2):254–63.

    Article  Google Scholar 

  27. Blomquist E, Engstrom ER, Borota L, Gál G, Nilsson K, Lewén A, et al. Positive correlation between occlusion rate and nidus size of proton beam treated brain arteriovenous malformations (AVMs). Acta Oncol. 2016;55(1):105–12.

    Article  Google Scholar 

  28. Silander H, Pellettieri L, Enblad P, Montelius A, Grusell E, Vallhagen-Dahlgren C, et al. Fractionated, stereotactic proton beam treatment of cerebral arteriovenous malformations. Acta Neurol Scand. 2004;109(2):85–90.

    Article  CAS  Google Scholar 

  29. Vernimmen FJ, Slabbert JP, Wilson JA, Fredericks S, Melvill R. Stereotactic proton beam therapy for intracranial arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2005;62(1):44–52.

    Article  Google Scholar 

  30. Seifert V, Stolke D, Mehdorn HM, Hoffmann B. Clinical and radiological evaluation of long-term results of stereotactic proton beam radiosurgery in patients with cerebral arteriovenous malformations. J Neurosurg. 1994;81(5):683–9.

    Article  CAS  Google Scholar 

  31. Tseitlina MA, Kizhaev EV, Luchin EI, et al. Proton three-dimensional conformal radiosurgery of arteriovenous malformation of the brain. Zh Vopr Neirokhir Im N N Burdenko. 2013;77(4):43–50; discussion 50.

    CAS  PubMed  Google Scholar 

  32. Levy RP, Schulte RW, Slater JD, Miller DW, Slater JM. Stereotactic radiosurgery--the role of charged particles. Acta Oncol. 1999;38(2):165–9.

    Article  CAS  Google Scholar 

  33. Lawrence JH. Proton irradiation of the pituitary. Cancer. 1957;10(4):795–8.

    Article  CAS  Google Scholar 

  34. Lawrence JH, Tobias CA, Born JL, Wangcc LJH. Heavy-particle irradiation in neoplastic and neurologic disease. J Neurosurg. 1962;19:717–22.

    Article  CAS  Google Scholar 

  35. Levy RP, Fabrikant JI, Frankel KA, Phillips MH, Lyman JT, Lawrence JH, et al. Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients. Stereotact Funct Neurosurg. 1991;57(1–2):22–35.

    Article  CAS  Google Scholar 

  36. Wattson DA, Tanguturi SK, Spiegel DY, Niemierko A, Biller BM, Nachtigall LB, et al. Outcomes of proton therapy for patients with functional pituitary adenomas. Int J Radiat Oncol Biol Phys. 2014;90(3):532–9.

    Article  Google Scholar 

  37. Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, et al. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab. 2009;94(9):3400–7.

    Article  CAS  Google Scholar 

  38. Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML. Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg. 2011;114(2):303–9.

    Article  Google Scholar 

  39. Murphy ES, Suh JH. Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys. 2011;79(4):985–97.

    Article  Google Scholar 

  40. Harsh GR, Thornton AF, Chapman PH, Bussiere MR, Rabinov JD, Loeffler JS. Proton beam stereotactic radiosurgery of vestibular schwannomas. Int J Radiat Oncol Biol Phys. 2002;54(1):35–44.

    Article  Google Scholar 

  41. Weber DC, Chan AW, Bussiere MR, Harsh GR 4th, Ancukiewicz M, Barker FG 2nd, et al. Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity. Neurosurgery. 2003;53(3):577–86; discussion 586–578

    Article  Google Scholar 

  42. Vernimmen FJ, Mohamed Z, Slabbert JP, Wilson J. Long-term results of stereotactic proton beam radiotherapy for acoustic neuromas. Radiother Oncol. 2009;90(2):208–12.

    Article  Google Scholar 

  43. Mitsumori M, Shrieve DC, Alexander E 3rd, Kaiser UB, Richardson GE, Black PM, et al. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys. 1998;42(3):573–80.

    Article  CAS  Google Scholar 

  44. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab. 2005;90(2):800–4.

    Article  CAS  Google Scholar 

  45. Erridge SC, Conkey DS, Stockton D, Strachan MW, Statham PF, Whittle IR, et al. Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. Radiother Oncol. 2009;93(3):597–601.

    Article  Google Scholar 

  46. Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53(2):407–21.

    Article  Google Scholar 

  47. Dinh J, Stoker J, Georges RH, Sahoo N, Zhu XR, Rath S, et al. Comparison of proton therapy techniques for treatment of the whole brain as a component of craniospinal radiation. Radiat Oncol. 2013;8:289.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Minesh P. Mehta .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chhabra, A.M., Chowdhary, M., Mehta, M.P. (2019). Charged-Particle Proton Radiosurgery. In: Trifiletti, D., Chao, S., Sahgal, A., Sheehan, J. (eds) Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-16924-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16924-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16923-7

  • Online ISBN: 978-3-030-16924-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics